(Q48029140)

7 February 2018

title

What Is the Clinical Impact of Macrolide Resistance? (English)

1 reference

7 February 2018

1

John R. Lonks

1 reference

7 February 2018

publication date

1 February 2004

1 reference

7 February 2018

Current infectious disease reports

published in

1 reference

7 February 2018

volume

6

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

7-12

1 reference

7 February 2018

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-004-0018-1

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-004-0018-1

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-004-0018-1

High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-004-0018-1

Fluoroquinolone and Macrolide Treatment Failure in Pneumococcal Pneumonia and Selection of Multidrug-Resistant Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-004-0018-1

Meningitis and pneumonia due to novel multiply resistant pneumococci

21 January 2018

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

1 reference

12 December 2020

Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin

1 reference

12 December 2020

Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy

1 reference

12 December 2020

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

1 reference

12 December 2020

In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models

1 reference

12 December 2020

Pneumonia caused by a pneumococcus resistant to erythromycin and lincomycin. Case report.

1 reference

12 December 2020

Emergence of macrolide resistance during treatment of pneumococcal pneumonia

1 reference

12 December 2020

Macrolide resistance among invasive Streptococcus pneumoniae isolates

1 reference

12 December 2020

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

1 reference

12 December 2020

Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology.

1 reference

12 December 2020

Efficacies of ABT-773, a new ketolide, against experimental bacterial infections

1 reference

12 December 2020

Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media

1 reference

12 December 2020

Breakthrough sepsis in macrolide-resistant pneumococcal infection

1 reference

12 December 2020

Streptococcus pneumoniae resistant to erythromycin and clindamycin

1 reference

12 December 2020

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

12 December 2020

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

1 reference

12 December 2020

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

1 reference

12 December 2020

Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams

1 reference

12 December 2020

Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study

1 reference

12 December 2020

Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children

1 reference

12 December 2020

National Ambulatory Medical Care Survey: 2001 summary.

1 reference

12 December 2020

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

1 reference

12 December 2020

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

12 December 2020

In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae

1 reference

12 December 2020

Penicillin-resistant pneumococci and community-acquired pneumonia

1 reference

12 December 2020

10.1007/S11908-004-0018-1

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018